Galcanezumab effect on “whole pain burden” and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience

被引：0
|
作者：
Marcello Silvestro
Alessandro Tessitore
Ilaria Orologio
Rosa De Micco
Lorenzo Tartaglione
Francesca Trojsi
Gioacchino Tedeschi
Antonio Russo
机构：
[1] University of Campania “Luigi Vanvitelli”,Headache Center, Department of Advanced Medical and Surgical Sciences (DAMSS)
来源：
The Journal of Headache and Pain | 2022年 / 23卷
关键词：
Galcanezumab; Migraine; Monoclonal antibodies; Real-world; CGRP;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 35 条
  • [1] Galcanezumab effect on "whole pain burden" and multidimensional outcomes in migraine patients with previous unsuccessful treatments: a real-world experience
    Silvestro, Marcello
    Tessitore, Alessandro
    Orologio, Ilaria
    De Micco, Rosa
    Tartaglione, Lorenzo
    Trojsi, Francesca
    Tedeschi, Gioacchino
    Russo, Antonio
    JOURNAL OF HEADACHE AND PAIN, 2022, 23 (01):
  • [2] Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience
    Antonio Russo
    Marcello Silvestro
    Fabrizio Scotto di Clemente
    Francesca Trojsi
    Alvino Bisecco
    Simona Bonavita
    Alessandro Tessitore
    Gioacchino Tedeschi
    The Journal of Headache and Pain, 2020, 21
  • [3] Multidimensional assessment of the effects of erenumab in chronic migraine patients with previous unsuccessful preventive treatments: a comprehensive real-world experience
    Russo, Antonio
    Silvestro, Marcello
    di Clemente, Fabrizio Scotto
    Trojsi, Francesca
    Bisecco, Alvino
    Bonavita, Simona
    Tessitore, Alessandro
    Tedeschi, Gioacchino
    JOURNAL OF HEADACHE AND PAIN, 2020, 21 (01):
  • [4] Real-world experience of galcanezumab in the prevention of migraine in Spain: a systematic literature review
    Pozo-Rosich, Patricia
    Garcia-Azorin, David
    Diaz-Cerezo, Silvia
    Fernandez-Montoya, Julia
    de Paz, Hector David
    Nunez, Mercedes
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [5] Effectiveness of galcanezumab on sleep quality, migraine outcome, and multidimensional patient-reported outcome measures: a real-world experience in Turkish patients with episodic and chronic migraine
    Ilgaz Aydinlar, Elif
    Erdogan Soyukibar, Tuba
    Yalinay Dikmen, Pinar
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [6] Real-world efficacy of galcanezumab for the treatment of migraine in Korean patients
    Kwon, Soonwook
    Gil, Young-Eun
    Lee, Mi Ji
    CEPHALALGIA, 2022, 42 (08) : 705 - 714
  • [7] Predictors of galcanezumab response in a real-world study of Korean patients with migraine
    Kim, Seung Ae
    Jang, Hyemin
    Lee, Mi Ji
    SCIENTIFIC REPORTS, 2023, 13 (01)
  • [8] Predictors of response to galcanezumab in patients with chronic migraine: a real-world prospective observational study
    Hyoung Cheol Lee
    Soohyun Cho
    Byung-Kun Kim
    Neurological Sciences, 2023, 44 : 2455 - 2463
  • [9] Predictors of response to galcanezumab in patients with chronic migraine: a real-world prospective observational study
    Lee, Hyoung Cheol
    Cho, Soohyun
    Kim, Byung-Kun
    NEUROLOGICAL SCIENCES, 2023, 44 (07) : 2455 - 2463
  • [10] Real-world experience of erenumab in patients with chronic or episodic migraine in the UAE
    Taoufik Alsaadi
    Suzan Noori
    Razmig Varakian
    Saly Youssef
    AbuBaker Almadani
    BMC Neurology, 22
1234